October 5, 2020 08:55 AM EDTUpdated 10:38 AM

Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated

Nicole DeFeudis

Editor

Max Gelman

Senior Editor

With Regeneron’s Covid-19 antibody cocktail being used to treat the highest-profile patient on the planet, one top analyst expects an EUA could be on the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated

Nicole DeFeudis

Editor

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Top an­a­lyst: Re­gen­eron EUA like­ly this week — un­less Trump takes a turn for worse; UK says less than half of res­i­dents will be vac­ci­nat­ed

Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated